FDG PET/CT Demonstration of Pancreatic Metastasis From Prostate Cancer.
Desai, Bhushan MBBS, MS *; Elatre, Wafaa MD +; Quinn, David I. MD, PhD ++; Jadvar, Hossein MD, PhD, MPH, MBA *
Clinical Nuclear Medicine.
36(10):961-962, October 2011.
(Format: HTML, PDF)
We report the hybrid FDG PET/CT appearance of a biopsy-proven pancreatic metastasis from prostate cancer in a man with castrate-resistant metastatic disease. The common sites of metastases from prostate cancer are bone and locoregional lymph nodes. Pancreas is an atypical location of metastasis from prostate cancer. PET/CT in this case helped with the targeted pathologic confirmation to differentiate primary pancreatic tumor from an unusual metastasis from prostate cancer which in turn affected the clinical management.
Copyright (C) 2011 Wolters Kluwer Health, Inc. All rights reserved.